Integrating genetic regulation and single-cell expression with GWAS prioritizes causal genes and cell types for glaucoma

Competing Interest Statement

Joshua R. Sanes is a consultant for Biogen, but none of this work benefits or benefited from that relationship. Tavé van Zyl is an employee of Regeneron. Anthony P. Khawaja has acted as a paid consultant or lecturer to Abbvie, Aerie, Allergan, Google Health, Heidelberg Engineering, Novartis, Reichert, Santen and Thea.

Funding Statement

This work was funded by NIH/NEI R01 EY031424-01 (AVS, ARH, JR, PAM), NIH/NEI P30 EY014104 (JLW, AVS), NIH/NEI EY032559-01 (JLW, AVS), and the Chan Zuckerberg Initiative (CZI) Seed Network for the Human Cell Atlas awards CZF2019-002459 (JRS, AVS, WY, AM) and CZF2019-002425 (QL, RC). XJ is supported by the University of Edinburgh and University of Helsinki joint PhD studentship program in Human Genomics. VV is supported by an MRC University Unit Programme grant (MC_UU_00007/10) (QTL in Health and Disease). APK is supported by a UK Research and Innovation Future Leaders Fellowship, an Alcon Research Institute Young Investigator Award and a Lister Institute for Preventive Medicine Award. This research was supported by the NIHR Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This work used publicly available summary statistics data of genome-wide association studies of complex human traits. The eye tissues samples subjected to single nucleus RNA-sequencing that was analyzed in this study were collected from de-identified, deceased donors under HIPAA Privacy Rules. The institutional review board (IRB) approvals for post-mortem tissue acquisition at Mass General Brigham (Rapid Autopsy Program) and University of Utah (partnership with Lions International) gave ethical approval for research with the tissue samples. No IRB approval is required for transcriptomic analysis of post-mortem tissues.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes